Company Profile

  1. You are here:    Home
  2. Search Databases
  3. Search Company Registry
  4. Company Profile

Hemotek
Profile last edited on: 8/22/2022      CAGE: 6SWU5      UEI: TQNKADND3NZ8

Business Identifier: Dialysis needles
Year Founded
2011
First Award
2014
Latest Award
2020
Program Status
Active
Popularity Index

Edit Company Profile

Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
  Explanation Edit

Location Information

1300 Valley House Drive Suite 100-18
Rohnert Park, CA 94928
   (707) 494-2895
   patrick@hemotekmedical.com
   hemotekmedical.com
Location: Single
Congr. District: 05
County: Sonoma

Public Profile

Hemotek is an early stage medtech company pursuing innovative ideas to improve the safety of dialysis. Hemotek's V-Needle replaces the regular dialysis needle and allows normal blood flow from the machine. The technology is designed to prevent blood loss from dialysis, which can cause serious injury or death.

Extent of SBIR involvement

User Avatar
Phase I Awards
2
Phase II Awards
1
Conversion Rate
50.00%
Phase I Dollars
$270,320
Phase II Dollars
$4,475,758
Total Awarded
$4,746,078

Synopsis: Awardee Business Condition

Employee Range
15-19
Revenue Range
1.5M-2M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
5-9

Awards Distribution by Agency

Most Recent SBIR Projects
Year Phase Agency Total Amount
2020 1 AF $49,920
Project Title: Hemotek Ox66 Powdered Oxygen
2020 2 NIH $4,696,158
Project Title: The V-Needle: a Failsafe Protection Against Needle Dislodgement During Dialysis

Key People / Management

  Charles Ventura -- Co-Founder and CEO

  Jack Woodmansee -- Chief Executive Officer

  Patrick J Rousche -- Co-founder and Chief Technology Officer

  Bill Shubin -- Director of Engineering

  Peter Tek -- Co-founder

Company News

There are no news available.